Synergetics Up 30% after Approval for Eye Surgery Device
At the time of writing, shares of Synergetics are at $4.96, up $1.09 so far today, or 28.17%. Synergetics designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. Synergetics USA Inc. has a market cap of $96.7 million; its shares were traded at around $4.95 with a P/E ratio of 16 and P/S ratio of 1.7. Synergetics USA Inc. had an annual average earnings growth of 13.7% over the past five years.
CEO David Hable recently purchased 4,000 shares of the company on 6/14/2012 at an average price of $4.03. On 3/15/2012, he had also purchased 4,000 shares. CFO Pamela Boone also bought 2,800 shares of the company at an average price of $4. There were various trades from other insiders as well.